Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4 to reflect a newer version of the page/template. This is a metadata change and does not alter the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-25T23:30:41.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A new endpoint, ‘Cumulative Percentage of Patients Remaining Distant Metastases-Free/Alive at 1yr and 2yrs After Initial Treatment,’ was added on 2026-07-16, and the previous endpoint ‘Percentage of Participants With Distant Metastases-free Survival’ was removed on 2026-06-16, reflecting a refinement of the distant metastases–free survival measure.
    Difference
    0.3%
    Check dated 2026-07-18T20:26:10.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's revision tag was updated to version v3.6.3, representing a small update to the page's template or backend tracking rather than any substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-07-04T13:29:55.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor backend/content-management update. No study information or user-facing content is affected.
    Difference
    0.1%
    Check dated 2026-06-27T08:03:57.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Results and related outcomes for the trial were posted, including Recurrence-free Survival, Overall Survival, DMFS, and CTCAE v5.0 adverse events, and a PDF of the Study Protocol and Statistical Analysis Plan was provided. The entries detailing previous result estimation text were removed.
    Difference
    2%
    Check dated 2026-06-20T05:54:45.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    New recruitment status note 'No longer looking for participants' and guidance sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the 'Intervention / Treatment' heading was standardized to 'Intervention/Treatment'. The footer revision label was updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:56:24.000Z thumbnail image

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.